Action IDP BIOGEN INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Biogen Inc. Xetra

Actions

IDP

US09062X1037

Marché Fermé - Xetra
Autres places de cotation
 17:35:58 21/06/2024 		Varia. 5j. Varia. 1 janv.
209 EUR -0,33% Graphique intraday de Biogen Inc. -3,29% -10,99%
13/06 REGENXBIO Inc. annonce des changements au niveau de la direction générale CI
12/06 Un dirigeant de Biogen minimise la concurrence imminente pour son médicament contre la maladie d'Alzheimer RE

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. (BIIB) - Contact Kessler Topaz Meltzer & Check, LLP
Biogen Inc. Class Action: Levi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIB
BIIB Investors Have Opportunity to lead Biogen Inc. Securities Fraud Lawsuit
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIB
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Lawsuit - BIIB
BIIB: Biogen Inc. Investor Reminder: Securities Fraud Class Action Lawsuit Was Filed Against Biogen Inc. - Contact Kessler Topaz Meltzer & Check, LLP
BIIB INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Shareholders of Biogen Inc. Should Contact The Gross Law Firm Before July 22, 2024 to Discuss Your Rights - BIIB
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Biogen Inc. of Class Action Lawsuit and Upcoming Deadlines - BIIB
Biogen Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
REGENXBIO Inc. Announces Chief Executive Officer Changes
Biogen executive plays down looming competition for its Alzheimer's drug
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…
Delta Flight Products (DFP) and Biogen collaborate on accessibility
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Japan's Nikkei gains on chip shares boost; Fed policy in focus
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
Panel asesor de la FDA vota a favor de los datos del fármaco contra el Alzheimer de Lilly
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action BIIB
  4. Action IDP
  5. Actualités Biogen Inc.
  6. Autres langues